Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wheeler

Showing results (871-880 of 902) with videos related to

Pageof 91
Sort By:
Elife|June 13, 2022
RNA-binding proteins direct myogenic cell fate decisionsJoshua R Wheeler, Oscar N Whitney, Thomas O Vogler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisMakaela Mews, Yousef Mustafa, Nicholas R Wheeler, et al.
Neuro-Oncology|February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaAlba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Nature|November 23, 2018
TDP-43 and RNA form amyloid-like myo-granules in regenerating muscleThomas O Vogler, Joshua R Wheeler, Eric D Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2003
The complete genome sequence of Mycobacterium bovisThierry Garnier, Karin Eiglmeier, Jean-Christophe Camus, et al.
Cancer Genetics|October 14, 2017
Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignanciesSandeep Mukherjee, Malini Sathanoori, Zeq Ma, et al.
BMJ Supportive & Palliative Care|February 22, 2023
Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind studyMeera R Agar, Anna K Nowak, Elizabeth J Hovey, et al.
Journal of Clinical and Translational Science|January 13, 2025
The role of information science within the clinical translational science ecosystemBart Ragon, Anne Seymour, Elizabeth C Whipple, et al.
International Journal of Molecular Sciences|May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineDavid Capper, Andreas von Deimling, Alba A Brandes, et al.
American Journal of Human Genetics|May 1, 2026
Multi-ancestry transcriptome-wide association study reveals shared and population-specific genetic effects in Alzheimer diseaseXinyu Sun, Makaela Mews, Nicholas R Wheeler, et al.
Pageof 91

Showing results (871-880 of 902) with videos related to

Sort By:
Pageof 91
Elife|June 13, 2022
RNA-binding proteins direct myogenic cell fate decisionsJoshua R Wheeler, Oscar N Whitney, Thomas O Vogler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisMakaela Mews, Yousef Mustafa, Nicholas R Wheeler, et al.
Neuro-Oncology|February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaAlba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Nature|November 23, 2018
TDP-43 and RNA form amyloid-like myo-granules in regenerating muscleThomas O Vogler, Joshua R Wheeler, Eric D Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2003
The complete genome sequence of Mycobacterium bovisThierry Garnier, Karin Eiglmeier, Jean-Christophe Camus, et al.
Cancer Genetics|October 14, 2017
Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignanciesSandeep Mukherjee, Malini Sathanoori, Zeq Ma, et al.
BMJ Supportive & Palliative Care|February 22, 2023
Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind studyMeera R Agar, Anna K Nowak, Elizabeth J Hovey, et al.
Journal of Clinical and Translational Science|January 13, 2025
The role of information science within the clinical translational science ecosystemBart Ragon, Anne Seymour, Elizabeth C Whipple, et al.
International Journal of Molecular Sciences|May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineDavid Capper, Andreas von Deimling, Alba A Brandes, et al.
American Journal of Human Genetics|May 1, 2026
Multi-ancestry transcriptome-wide association study reveals shared and population-specific genetic effects in Alzheimer diseaseXinyu Sun, Makaela Mews, Nicholas R Wheeler, et al.
Pageof 91